Nancy Sohler to Substance Abuse, Intravenous
This is a "connection" page, showing publications Nancy Sohler has written about Substance Abuse, Intravenous.
Connection Strength
0.858
-
Cunningham CO, Arnsten JH, Zhang C, Heo M, Bachhuber MA, Jost JJ, Grossberg R, Stein MR, Sohler NL. Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial. Drug Alcohol Depend. 2020 11 01; 216:108230.
Score: 0.612
-
Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat. 2015 Jan; 48(1):112-6.
Score: 0.101
-
Shah PA, Sohler NL, L?pez C, Fox AD, Cunningham CO. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program. J Opioid Manag. 2013 Nov-Dec; 9(6):407-13.
Score: 0.096
-
L?pez-Castro T, Sohler N, Riback L, Bravo G, Ohlendorf E, Ghiroli M, Fox AD. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care. Harm Reduct J. 2024 06 01; 21(1):108.
Score: 0.050